Logo image of OPXS

OPTEX SYSTEMS HOLDINGS INC (OPXS) Stock Fundamental Analysis

USA - NASDAQ:OPXS - US68384X2099 - Common Stock

12.08 USD
+0.19 (+1.6%)
Last: 9/15/2025, 8:00:02 PM
Fundamental Rating

6

Overall OPXS gets a fundamental rating of 6 out of 10. We evaluated OPXS against 69 industry peers in the Aerospace & Defense industry. OPXS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. OPXS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

OPXS had positive earnings in the past year.
In the past year OPXS had a positive cash flow from operations.
OPXS had positive earnings in each of the past 5 years.
OPXS had a positive operating cash flow in 4 of the past 5 years.
OPXS Yearly Net Income VS EBIT VS OCF VS FCFOPXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

The Return On Assets of OPXS (17.60%) is better than 98.55% of its industry peers.
OPXS has a Return On Equity of 22.20%. This is amongst the best in the industry. OPXS outperforms 89.86% of its industry peers.
OPXS has a better Return On Invested Capital (21.02%) than 100.00% of its industry peers.
OPXS had an Average Return On Invested Capital over the past 3 years of 13.10%. This is above the industry average of 8.22%.
The 3 year average ROIC (13.10%) for OPXS is below the current ROIC(21.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROIC 21.02%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
OPXS Yearly ROA, ROE, ROICOPXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

OPXS's Profit Margin of 13.01% is amongst the best of the industry. OPXS outperforms 86.96% of its industry peers.
OPXS's Profit Margin has declined in the last couple of years.
OPXS has a better Operating Margin (16.11%) than 85.51% of its industry peers.
OPXS's Operating Margin has improved in the last couple of years.
OPXS has a better Gross Margin (28.02%) than 62.32% of its industry peers.
OPXS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
OPXS Yearly Profit, Operating, Gross MarginsOPXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OPXS is creating value.
Compared to 1 year ago, OPXS has more shares outstanding
The number of shares outstanding for OPXS has been reduced compared to 5 years ago.
The debt/assets ratio for OPXS has been reduced compared to a year ago.
OPXS Yearly Shares OutstandingOPXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
OPXS Yearly Total Debt VS Total AssetsOPXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 11.10 indicates that OPXS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.10, OPXS belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
There is no outstanding debt for OPXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.1
ROIC/WACC2.17
WACC9.68%
OPXS Yearly LT Debt VS Equity VS FCFOPXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.14 indicates that OPXS has no problem at all paying its short term obligations.
OPXS has a better Current ratio (5.14) than 94.20% of its industry peers.
OPXS has a Quick Ratio of 2.05. This indicates that OPXS is financially healthy and has no problem in meeting its short term obligations.
OPXS's Quick ratio of 2.05 is fine compared to the rest of the industry. OPXS outperforms 68.12% of its industry peers.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 2.05
OPXS Yearly Current Assets VS Current LiabilitesOPXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

OPXS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.09%, which is quite impressive.
Measured over the past 5 years, OPXS shows a small growth in Earnings Per Share. The EPS has been growing by 4.27% on average per year.
Looking at the last year, OPXS shows a very strong growth in Revenue. The Revenue has grown by 21.00%.
OPXS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.74% yearly.
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPXS Yearly Revenue VS EstimatesOPXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.32, which indicates a correct valuation of OPXS.
Compared to the rest of the industry, the Price/Earnings ratio of OPXS indicates a rather cheap valuation: OPXS is cheaper than 97.10% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of OPXS to the average of the S&P500 Index (27.27), we can say OPXS is valued slightly cheaper.
Industry RankSector Rank
PE 16.32
Fwd PE N/A
OPXS Price Earnings VS Forward Price EarningsOPXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OPXS indicates a rather cheap valuation: OPXS is cheaper than 95.65% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of OPXS indicates a rather cheap valuation: OPXS is cheaper than 98.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.39
EV/EBITDA 11.21
OPXS Per share dataOPXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of OPXS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.82
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OPXS!.
Industry RankSector Rank
Dividend Yield N/A

OPTEX SYSTEMS HOLDINGS INC

NASDAQ:OPXS (9/15/2025, 8:00:02 PM)

12.08

+0.19 (+1.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)12-17 2025-12-17
Inst Owners32.94%
Inst Owner Change8.17%
Ins Owners17.29%
Ins Owner Change-5.4%
Market Cap83.47M
AnalystsN/A
Price TargetN/A
Short Float %0.49%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.32
Fwd PE N/A
P/S 2.11
P/FCF 15.39
P/OCF 13.64
P/B 3.61
P/tB 3.75
EV/EBITDA 11.21
EPS(TTM)0.74
EY6.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.79
FCFY6.5%
OCF(TTM)0.89
OCFY7.33%
SpS5.71
BVpS3.35
TBVpS3.23
PEG (NY)N/A
PEG (5Y)3.82
Profitability
Industry RankSector Rank
ROA 17.6%
ROE 22.2%
ROCE 25.99%
ROIC 21.02%
ROICexc 26.24%
ROICexgc 27.42%
OM 16.11%
PM (TTM) 13.01%
GM 28.02%
FCFM 13.74%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
ROICexc(3y)13.88%
ROICexc(5y)N/A
ROICexgc(3y)14.18%
ROICexgc(5y)N/A
ROCE(3y)16.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.64%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.31%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 130.21%
Cap/Sales 1.76%
Interest Coverage 219.38
Cash Conversion 88.75%
Profit Quality 105.63%
Current Ratio 5.14
Quick Ratio 2.05
Altman-Z 11.1
F-Score7
WACC9.68%
ROIC/WACC2.17
Cap/Depr(3y)182.71%
Cap/Depr(5y)142.72%
Cap/Sales(3y)2.57%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.09%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%21.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%22.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.62%
EBIT growth 3YN/A
EBIT growth 5Y8.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y431.2%
FCF growth 3Y-37.72%
FCF growth 5Y24.08%
OCF growth 1Y589.91%
OCF growth 3Y54.71%
OCF growth 5Y61.92%